Initially, we confirmed the upregulated expression of EGFR and DR4/5, at the protein level by immunohistochemistry of tissue sections from an NSCLC patient compared with sections of a healthy/normal lung (Fig. 1B; Supplementary Supplementary Fig. S1). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.